Clarke, C. J. and Holyoake, T. L. (2017) Preclinical approaches in chronic myeloid leukemia: from cells to systems. Experimental Hematology, 47, pp. 13-23. (doi: 10.1016/j.exphem.2016.11.005) (PMID:28017647) (PMCID:5333535)
|
Text
133548.pdf - Published Version Available under License Creative Commons Attribution. 756kB |
Abstract
Advances in the design of targeted therapies for the treatment of chronic myeloid leukemia (CML) have transformed the prognosis for patients diagnosed with this disease. However, leukemic stem cell persistence, drug intolerance, drug resistance, and advanced-phase disease represent unmet clinical needs demanding the attention of CML investigators worldwide. The availability of appropriate preclinical models is essential to efficiently translate findings from the bench to the clinic. Here we review the current approaches taken to preclinical work in the CML field, including examples of commonly used in vivo models and recent successes from systems biology-based methodologies.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Holyoake, Professor Tessa and Clarke, Dr Cassie |
| Authors: | Clarke, C. J., and Holyoake, T. L. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
| Journal Name: | Experimental Hematology |
| Publisher: | Elsevier |
| ISSN: | 0301-472X |
| ISSN (Online): | 1873-2399 |
| Published Online: | 23 December 2016 |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information